Suppr超能文献

综述:病毒感染与血栓形成和出血的机制。

Review: Viral infections and mechanisms of thrombosis and bleeding.

机构信息

Department of Virology, Erasmus Medical Centre, University of Rotterdam, Rotterdam, The Netherlands.

出版信息

J Med Virol. 2012 Oct;84(10):1680-96. doi: 10.1002/jmv.23354.

Abstract

Viral infections are associated with coagulation disorders. All aspects of the coagulation cascade, primary hemostasis, coagulation, and fibrinolysis, can be affected. As a consequence, thrombosis and disseminated intravascular coagulation, hemorrhage, or both, may occur. Investigation of coagulation disorders as a consequence of different viral infections have not been performed uniformly. Common pathways are therefore not fully elucidated. In many severe viral infections there is no treatment other than supportive measures. A better understanding of the pathophysiology behind the association of viral infections and coagulation disorders is crucial for developing therapeutic strategies. This is of special importance in case of severe complications, such as those seen in hemorrhagic viral infections, the incidence of which is increasing worldwide. To date, only a few promising targets have been discovered, meaning the implementation in a clinical context is still hampered. This review discusses non-hemorrhagic and hemorrhagic viruses for which sufficient data on the association with hemostasis and related clinical features is available. This will enable clinicians to interpret research data and place them into a perspective.

摘要

病毒感染与凝血障碍有关。凝血级联的各个方面,包括初始止血、凝血和纤维蛋白溶解,都可能受到影响。因此,可能会发生血栓形成和弥散性血管内凝血、出血或两者兼有。针对不同病毒感染导致的凝血障碍的研究并未统一进行。因此,共同途径尚未完全阐明。在许多严重的病毒感染中,除了支持性治疗外,没有其他治疗方法。更好地了解病毒感染和凝血障碍之间的病理生理学关联对于制定治疗策略至关重要。在严重并发症的情况下尤其如此,例如在出血性病毒感染中所见的并发症,其发病率在全球范围内正在上升。迄今为止,仅发现了少数有希望的靶点,这意味着在临床环境中的实施仍然受到阻碍。本综述讨论了具有足够关于止血和相关临床特征的关联数据的非出血性和出血性病毒。这将使临床医生能够解释研究数据并将其置于适当的背景下。

相似文献

1
Review: Viral infections and mechanisms of thrombosis and bleeding.
J Med Virol. 2012 Oct;84(10):1680-96. doi: 10.1002/jmv.23354.
2
Viruses and hemostasis.
Rev Infect Dis. 1989 May-Jun;11 Suppl 4:S672-88. doi: 10.1093/clinids/11.supplement_4.s672.
5
Hemostasis: old system, new players, new directions.
Thromb Res. 2014 May;133 Suppl 1:S1-2. doi: 10.1016/j.thromres.2014.03.001.
6
Propensity for hemorrhage and thrombosis in chronic myeloproliferative disorders.
Semin Hematol. 2004 Apr;41(2 Suppl 3):10-4. doi: 10.1053/j.seminhematol.2004.02.008.
8
Alterations of hemostasis associated with malignancy: etiology, pathophysiology, diagnosis and management.
Semin Thromb Hemost. 1978 Summer;5(1):1-26. doi: 10.1055/s-0028-1087142.
9
Molecular challenges and viral diseases.
Haemophilia. 2003 Nov;9(6):727-37. doi: 10.1046/j.1351-8216.2003.00827.x.
10
[Thrombohemorrhagic theory of general pathology].
Usp Fiziol Nauk. 1986 Apr-Jun;17(2):56-82.

引用本文的文献

3
COVID-19 and acute limb ischemia: latest hypotheses of pathophysiology and molecular mechanisms.
J Zhejiang Univ Sci B. 2025 Feb 19;26(4):333-352. doi: 10.1631/jzus.B2300512.
4
Exploring Central Venous Thrombosis as a Rare Postinfectious Complication of Dengue: A Case Report.
Case Rep Neurol Med. 2025 Apr 1;2025:5368634. doi: 10.1155/crnm/5368634. eCollection 2025.
5
Clinical and laboratory profiles of dengue infection in the hospitals in North Jakarta, Indonesia.
IJID Reg. 2025 Feb 23;14:100612. doi: 10.1016/j.ijregi.2025.100612. eCollection 2025 Mar.
6
Key influencers in an aneurysmal thrombosis model: A sensitivity analysis and validation study.
APL Bioeng. 2025 Feb 11;9(1):016107. doi: 10.1063/5.0223753. eCollection 2025 Mar.
7
The Effects of Mucolytic Agents N-Acetylcysteine and Erdosteine on Hemostasis in Humans.
Sovrem Tekhnologii Med. 2024;16(4):55-60. doi: 10.17691/stm2024.16.4.06. Epub 2024 Aug 30.
8
The Influence of SARS-CoV-2 Infection on the Development of Selected Neurological Diseases.
Int J Mol Sci. 2024 Aug 9;25(16):8715. doi: 10.3390/ijms25168715.
9
Viruses and thrombocytopenia.
Heliyon. 2024 Mar 16;10(6):e27844. doi: 10.1016/j.heliyon.2024.e27844. eCollection 2024 Mar 30.
10
New Directions in Infection-Associated Ischemic Stroke.
J Clin Neurol. 2024 Mar;20(2):140-152. doi: 10.3988/jcn.2023.0056. Epub 2024 Feb 5.

本文引用的文献

1
The significance of autoantibodies against β2-glycoprotein I.
Blood. 2012 Jul 12;120(2):266-74. doi: 10.1182/blood-2012-03-378646. Epub 2012 May 2.
3
Viral hepatitis and thrombosis: a narrative review.
Semin Thromb Hemost. 2012 Jul;38(5):530-4. doi: 10.1055/s-0032-1305783. Epub 2012 Mar 7.
4
Platelet apoptosis and apoptotic platelet clearance by macrophages in secondary dengue virus infections.
J Infect Dis. 2012 Apr 15;205(8):1321-9. doi: 10.1093/infdis/jis180. Epub 2012 Mar 1.
5
Tissue factor and glycoprotein C on herpes simplex virus type 1 are protease-activated receptor 2 cofactors that enhance infection.
Blood. 2012 Apr 12;119(15):3638-45. doi: 10.1182/blood-2011-08-376814. Epub 2012 Feb 28.
7
Crosstalk between inflammation and coagulation: the lessons of sepsis.
Curr Vasc Pharmacol. 2012 Sep;10(5):632-8. doi: 10.2174/157016112801784549.
8
Evaluation of the 2009 WHO dengue case classification in an Indonesian pediatric cohort.
Am J Trop Med Hyg. 2012 Jan;86(1):166-70. doi: 10.4269/ajtmh.2012.11-0491.
9
Hemorrhagic fever caused by a novel Bunyavirus in China: pathogenesis and correlates of fatal outcome.
Clin Infect Dis. 2012 Feb 15;54(4):527-33. doi: 10.1093/cid/cir804. Epub 2011 Dec 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验